Health · Medical Research · 2 hrs ago

GLP-1 drugs did not significantly change injection frequency for diabetic eye disease

GLP-1 drugs did not significantly change injection frequency for diabetic eye disease

A large study found GLP-1 drugs did not significantly change injection frequency for people with diabetic macular edema.

The study was presented in New Orleans and looked at anti-VEGF injections, a treatment used for the condition.

It was a retrospective cohort study, meaning researchers examined existing patient information.

The researchers tracked treatment over 24 months of follow-up.

The finding suggests GLP-1 drugs did not lead to a sustained change in how often patients received injections.

The study does not establish what happens beyond those 24 months.

Sources

Related news